CSTONE PHARMA-B(02616): ACAAI 2025 | CS2015 (OX40L/TSLP bispecific antibody) made its first international academic appearance.
KStone Pharma-B (02616) announced that the company will participate in the 2025 American Academy of Allergy, Asthma and Immunology (A...
CSTONE PHARMA-B (02616) announced that the company will present one of its pipeline candidates, CS2015 (OX40L/TSLP bispecific antibody), at the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Scientific Meeting in 2025 in the form of an electronic poster and oral presentation. ACAAI is one of the most influential academic conferences in the global allergy, asthma, and immunology field, attracting experts and scholars from around the world to discuss the latest research findings. This will be the first international appearance of CS2015 at an academic conference, and the abstract and full content of the electronic poster are now officially available on the ACAAI website.
CS2015 adopts an asymmetric molecular structure, targeting both OX40L and TSLP, two key regulatory factors in type 2 inflammation that have been clinically validated to effectively block inflammation. The molecule utilizes a mutated Fc to weaken its binding with FcR and prolong its circulating half-life in the body, ultimately optimizing pharmacokinetic (PK) characteristics and supporting long dosing intervals. The excellent molecular stability of CS2015 provides assurance for the development of high-concentration subcutaneous formulations. Additionally, its outstanding developability lays the foundation for high yield and large-scale production.
Related Articles

HK Stock Market Move | YEEBO (INT'L H) (00259) jumped over 9%, with the expected mid-term net profit increasing by approximately 1.2 billion Hong Kong dollars compared to the same period last year.

HK Stock Market Move | Asymchem Laboratories (06821) rose by over 3%, with the net profit attributable to the mother increasing by 12.66% year-on-year in the first three quarters. Emerging businesses are expected to become the core growth engine.

HK Stock Market Move | DONGYUE GROUP (00189) rose more than 5% with the concept of silicon exploding. Subsidiary Shandong Dongyue Silicone Material rose limit in early trading.
HK Stock Market Move | YEEBO (INT'L H) (00259) jumped over 9%, with the expected mid-term net profit increasing by approximately 1.2 billion Hong Kong dollars compared to the same period last year.

HK Stock Market Move | Asymchem Laboratories (06821) rose by over 3%, with the net profit attributable to the mother increasing by 12.66% year-on-year in the first three quarters. Emerging businesses are expected to become the core growth engine.

HK Stock Market Move | DONGYUE GROUP (00189) rose more than 5% with the concept of silicon exploding. Subsidiary Shandong Dongyue Silicone Material rose limit in early trading.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


